<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: novartis ag</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Novartis posts profit gain thanks to new drugs (Update)</title>
   	 <description>(AP)—Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and emerging markets.</description>
     <link>http://medicalxpress.com/news/2013-04-novartis-profit-gain-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 24 Apr 2013 08:07:38 EST</pubDate>
	 <guid isPermaLink="false">news286009650</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/novartispost.jpg" width="90" height="90" />
</item>
<item>
     <title>India's rejection of drug patent could reverberate</title>
   	 <description>The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers.</description>
     <link>http://medicalxpress.com/news/2013-04-india-drug-patent-reverberate.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 01 Apr 2013 19:11:06 EST</pubDate>
	 <guid isPermaLink="false">news284062257</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/indiasreject.jpg" width="90" height="90" />
</item>
<item>
     <title>Drug maker Novartis loses India patent battle (Update)</title>
   	 <description>India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.</description>
     <link>http://medicalxpress.com/news/2013-04-drug-maker-india-patent.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 01 Apr 2013 04:28:55 EST</pubDate>
	 <guid isPermaLink="false">news284009309</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/drugmakerlos.jpg" width="90" height="90" />
</item>
<item>
     <title>India's top court to deliver Novartis judgment</title>
   	 <description>India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they should be allowed to continue producing cheaper generic versions of many lifesaving medicines.</description>
     <link>http://medicalxpress.com/news/2013-03-india-court-novartis-judgment.html</link>
	 <category>Medications</category>
	 <pubDate>Sun, 31 Mar 2013 09:20:01 EST</pubDate>
	 <guid isPermaLink="false">news283939647</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/indiastopcou.jpg" width="90" height="90" />
</item>
<item>
     <title>Novartis Q4 net profit rebounds to $2.1 billion</title>
   	 <description>(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.</description>
     <link>http://medicalxpress.com/news/2013-01-novartis-q4-net-profit-rebounds.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 23 Jan 2013 03:52:12 EST</pubDate>
	 <guid isPermaLink="false">news278135436</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/novartisq4ne.jpg" width="90" height="90" />
</item>
<item>
     <title>Indian court to rule on generic drug industry</title>
   	 <description>(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.</description>
     <link>http://medicalxpress.com/news/2013-01-indian-court-drug-industry.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 04 Jan 2013 04:57:22 EST</pubDate>
	 <guid isPermaLink="false">news276497833</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/indiancourtt.jpg" width="90" height="90" />
</item>
<item>
     <title>EU drug regulator OKs Novartis' meningitis B shot</title>
   	 <description>Europe's top drug regulator has recommended approval for the first vaccine against meningitis B, made by Novartis AG.</description>
     <link>http://medicalxpress.com/news/2012-11-eu-drug-oks-novartis-meningitis.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 16 Nov 2012 08:54:14 EST</pubDate>
	 <guid isPermaLink="false">news272278445</guid>
	 
</item>
<item>
     <title>EU approves Novartis-Incyte blood cancer drug</title>
   	 <description>Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.</description>
     <link>http://medicalxpress.com/news/2012-09-eu-novartis-incyte-blood-cancer-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 04 Sep 2012 08:10:37 EST</pubDate>
	 <guid isPermaLink="false">news265965018</guid>
	 
</item>
<item>
     <title>Novartis drug investigated after 11 deaths</title>
   	 <description>A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.</description>
     <link>http://medicalxpress.com/news/2012-01-novartis-drug-deaths.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 20 Jan 2012 13:29:55 EST</pubDate>
	 <guid isPermaLink="false">news246288586</guid>
	 
</item>
<item>
     <title>Study: Bone drug boosts breast cancer survival</title>
   	 <description>(AP) --  Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug improved survival, as much as many chemotherapies do.</description>
     <link>http://medicalxpress.com/news/2011-12-bone-drug-boosts-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 09 Dec 2011 03:10:01 EST</pubDate>
	 <guid isPermaLink="false">news242621950</guid>
	 
</item>
<item>
     <title>Big promise is seen in 2 new breast cancer drugs</title>
   	 <description>(AP) --  Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.</description>
     <link>http://medicalxpress.com/news/2011-12-big-breast-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 08 Dec 2011 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news242540493</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/bigpromiseis.jpg" width="90" height="90" />
</item>
<item>
     <title>Novartis fights patent rejection in Indian court</title>
   	 <description>(AP) --  In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis AG for its lifesaving cancer treatment Gleevec.</description>
     <link>http://medicalxpress.com/news/2011-09-novartis-patent-indian-court.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 06 Sep 2011 10:22:55 EST</pubDate>
	 <guid isPermaLink="false">news234523359</guid>
	 
</item>


</channel>
</rss>
